Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig T Wallington-Beddoe

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Hematology & Oncology|September 24, 2021
Prognostic and predictive biomarker developments in multiple myelomaCraig T Wallington-Beddoe, Rachel L Mynott
ACS Pharmacology & Translational Science|June 21, 2021
Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple MyelomaRachel L Mynott, Craig T Wallington-Beddoe
ACS Pharmacology & Translational Science|April 16, 2021
Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma CellsRachel L Mynott, Craig T Wallington-Beddoe
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 9, 2019
Sphingolipids and the unfolded protein responseMelissa K Bennett, Craig T Wallington-Beddoe, Stuart M Pitson
British Journal of Haematology|March 26, 2013
Oncogenic properties of sphingosine kinases in haematological malignanciesCraig T Wallington-Beddoe, Kenneth F Bradstock, Linda J Bendall
Autophagy|April 5, 2011
FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cellsCraig T Wallington-Beddoe, John Hewson, Kenneth F Bradstock, et al.
British Journal of Haematology|April 21, 2018
Resistance to proteasome inhibitors and other targeted therapies in myelomaCraig T Wallington-Beddoe, Magdalena Sobieraj-Teague, Bryone J Kuss, et al.
Cell Death Discovery|August 1, 2018
Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
Biomarker Research|February 15, 2018
Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in miceVicki Xie, Daochen Tong, Craig T Wallington-Beddoe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myelomaCraig T Wallington-Beddoe, David J Gottlieb, Fran Garvin, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Hematology & Oncology|September 24, 2021
Prognostic and predictive biomarker developments in multiple myelomaCraig T Wallington-Beddoe, Rachel L Mynott
ACS Pharmacology & Translational Science|June 21, 2021
Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple MyelomaRachel L Mynott, Craig T Wallington-Beddoe
ACS Pharmacology & Translational Science|April 16, 2021
Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma CellsRachel L Mynott, Craig T Wallington-Beddoe
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 9, 2019
Sphingolipids and the unfolded protein responseMelissa K Bennett, Craig T Wallington-Beddoe, Stuart M Pitson
British Journal of Haematology|March 26, 2013
Oncogenic properties of sphingosine kinases in haematological malignanciesCraig T Wallington-Beddoe, Kenneth F Bradstock, Linda J Bendall
Autophagy|April 5, 2011
FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cellsCraig T Wallington-Beddoe, John Hewson, Kenneth F Bradstock, et al.
British Journal of Haematology|April 21, 2018
Resistance to proteasome inhibitors and other targeted therapies in myelomaCraig T Wallington-Beddoe, Magdalena Sobieraj-Teague, Bryone J Kuss, et al.
Cell Death Discovery|August 1, 2018
Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
Biomarker Research|February 15, 2018
Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in miceVicki Xie, Daochen Tong, Craig T Wallington-Beddoe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myelomaCraig T Wallington-Beddoe, David J Gottlieb, Fran Garvin, et al.
Pageof 2